Search results
Kansas Citians with sickle cell disease may benefit from new FDA-approved treatments
Kansas City Star via Yahoo Canada News· 7 months agoSickle cell disease affects about 100,000 people in the United States, including an estimated 2,000...
Geron says blood cancer drug succeeds in late-stage study, shares surge
Reuters via Yahoo Canada News· 2 years ago(Reuters) -Geron Corp said on Wednesday its experimental drug helped more patients with a...
BLUE, CRSP & VRTX Down Despite FDA Nod to SCD Therapies
Zacks via Yahoo Finance Canada· 7 months agoThe FDA approves two one-time gene therapies for treating sickle cell disease. One of them utilizes...
Editas (EDIT) Stock Gains 23% in the Past 6 Months: Here's Why
Zacks via Yahoo Finance Canada· 6 months agoEditas (EDIT) shares have gained 23% in the past six months, driven by encouraging findings from the...
Editas (EDIT) Licenses Cas9 Tool to Vertex, Stock Up 6%
Zacks via Yahoo Finance Canada· 7 months agoEditas (EDIT) stock rises 6% on a non-exclusive agreement with Vertex Pharmaceuticals to license its...
Vertex (VRTX), CRISPR Get Positive CHMP Opinion for Gene-Therapy
Zacks via Yahoo Finance Canada· 7 months agoVertex Pharmaceuticals Incorporated VRTX announced that the Committee for Medicinal Products for...
Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance Canada· 5 months agoRoivant Sciences Ltd. (NASDAQ:ROIV) Q3 2023 Earnings Call Transcript February 13, 2024 Roivant...
Q2 2023 AcelRx Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance Canada· 11 months agoParticipants Pamela Pierce Palmer; Co-Founder, Chief Medical Officer & Director; AcelRx Pharmaceuticals, Inc. Raffi Mark Asadorian; CFO; AcelRx Pharmaceuticals, Inc. Vincent J. Angotti; CEO ...